« Previous
Next »
Current Problems in Diagnostic Radiology
Volume 38, Issue 2
, Pages 68-83
, March 2009
Practical Applications of Nuclear Medicine in Imaging Breast Cancer
References
- . Breast scintigraphy today: Indications and limitations. Eur J Nucl Med Mol Imaging. 2004;31(suppl 1):S35–S45
- . Clinical applications of 99mTc-sestamibi scintimammography. Semin Nucl Med. 2005;35:100–115
- Procedure guideline for breast scintigraphy (Society of Nuclear Medicine). J Nucl Med. 1999;40:1233–1235
- Scintimammography with a hybrid SPECT/CT imaging system. Anticancer Res. 2007;27:557–562
- . A meta-analysis of scintimammography: An evidence-based approach to its clinical utility. Nucl Med Commun. 2006;27:589–594
- High-resolution scintimammography: a pilot study. J Nucl Med. 2002;43:909–915
- Occult breast cancer: Scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology. 2005;237:274–280
- Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med. 2003;44:602–609
- Molecular breast imaging: A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc. 2005;80:24–30
- Molecular breast imaging: Advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 2007;13:3–11
- Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: The nuclear medicine perspective. J Surg Oncol. 2004;85:112–122
- . Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188:49–61
- . Sentinel lymph node in breast cancer. Curr Opin Obstet Gynecol. 2006;18:53–58
- Lymphatic mapping: A technique providing accurate staging for breast cancer. Breast Cancer. 1999;6:145–154
- . Injection of (99m)Tc-labeled sulfur colloid the day before operation for breast cancer sentinel lymph node mapping is as successful as injection the day of operation. Am J Surg. 2004;188:685–689
- . A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping. Am J Surg. 2004;188:423–425
- Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol. 2005;31:942–948
- Innovative diagnostics for breast cancer: new frontiers for the new millennium using radioactive seed localization. Surg Forum. 1999;50:348–349
- Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). Am J Surg. 2001;182:404–406
- Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: Radioactive seed versus wire localization. Ann Surg Oncol. 2001;8:711–715
- Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188:377–380
- Radiation safety with use of I-125 seeds for localization of nonpalpable breast lesions. Acad Radiol. 2006;13:909–915
- . Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography. Breast Cancer Res. 2005;7:153–162
- . Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2005;35:84–99
- . The role of positron emission tomographic imaging in breast cancer. Curr Oncol Rep. 2004;6:62–68
- Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging. 2006;33:254–262
- . FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging. 2004;31(suppl 1):S70–S79
- . FDG-PET and beyond: Molecular breast cancer imaging. J Clin Oncol. 2005;23:1664–1673
- Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations. J Clin Oncol. 2000;18:3495–3502
- Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics. 2002;22:5–17
- . The value of FDG positron emission tomography in the management of patients with breast cancer. Breast J. 2005;11:204–209
- . A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat. 2005;90:105–112
- Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med. 2002;43:325–329
- The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer. World J Surg. 2006;30:1422–1427
- High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J. 2006;12:309–323
PII: S0363-0188(07)00079-5
doi: 10.1067/j.cpradiol.2007.10.003
© 2009 Mosby, Inc. All rights reserved.
« Previous
Next »
Current Problems in Diagnostic Radiology
Volume 38, Issue 2
, Pages 68-83
, March 2009
